This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Moderna Inc. shed 7.5% to $63.15 on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 1.5% to 25,881.95 and Dow Jones Industrial Average falling 0.2% to 52,552.97.
The stock's fall snapped a two-day winning streak.
Moderna Inc. closed 26.2% short of its 52-week high of $85.60, which the company reached on July 6th.
The stock underperformed when compared to some of its peers, as Johnson & Johnson rose 1.2% to $249.97, Pfizer Inc. rose 1.3% to $25.14, and Gilead Sciences Inc. rose 3.49% to $136.30.
Trading volume totaled 5.6 million, compared to the 50-day average of 8.3 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
July 16, 2026 16:32 ET (20:32 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments